Dutch urologists say prostate cancer screening “cannot be justified”

A new review by specialists from Erasmus University Medical Center, just published in Prostate Cancer and Prostatic Diseases, states categorically that mass, population-based screening  for prostate cancer “cannot be justified yet in the context of a public health policy.” … READ MORE …

Some common sense about prostate cancer screening … from Australia

A new article in the Australian Medical Journal is titled, “It’s time to depolarise the unhelpful PSA-testing debate and put into practice lessons from the two major international screening trials.” We think this article makes a lot of sense. … READ MORE …

Prostate cancer news reports: Thursday, October, 2009

In today’s news reports we cover items on:

  • Risks for prostate cancer from  smoking and increased adipose tissue
  • The role of religious activities in prostate cancer testing among African Americans
  • Blood loss at the time of surgery and risk for progressive disease … READ MORE …

Prostate cancer news reports: Tuesday, June 16, 2009

This morning’s news reports address:

  • Patterns of use of PSA and DRE testing in the USA
  • The value of ADT in men receiving combined brachytherapy + EBRT
  • Skeletal and cardiovascular adverse effects of ADT
  • LHRH agonist treatment and effects on LHRH agonist receptors … READ MORE …

Do PCPs actually hold pre-testing discussions with patients about prostate cancer risk?

Even though many medical organizations recommend discussions between patients and their doctors before testing of individuals for risk of prostate cancer, there are few hard data about how primary care physicians (PCPs) actually apply thee guidelines to promote informed decision making for prostate cancer testing. … READ MORE …

And to add to the confusion about annual prostate cancer screening …

… a paper from the University of Texas Health Sciences Center in San Antonio has provided a detailed analysis of the spectrum of variation of PSA and DRE data among men in an earlier screening program. … READ MORE …

What Johns Hopkins has to say about the screening controversy

Many readers may be interested in seeing what Johns Hopkins has to say about the two studies published just over a week ago in the New England Journal of Medicine.

This topic is addressed under the heading “Recent PSA Studies: What You Need To Know” in the latest issue of Health Alerts. Interestingly, in this article, Dr. H. Ballentine Carter seems to come down fairly firmly in the same camp as editorialist Michael J. Barry, MD, in his comments on these studies in the New England Journal of Medicine itself.